
--- Page 1 ---
1e-0-3 Csscnomn, mfiltnut'wg duct,nos 85os/3 c50.q She: Busst, Nos 1/2/ Procedure Date: Procedure Physician: Attending Physician/Copies To: UUID:16DEA43F-4A61-44E3-854F-686575B45628 TCGA-BH-A1EV-01A-PR Redacted Patient history: *'nnDaTE of LMp: * DATE OF LAST DELIVERY: * PRE-OP DIAGNOSIS: L BREAST CA. POST-OP DIAGNOSIS: SAME OPERATIVE PROCEDURE: L NOD RAD NAST CLINICAL HISTORY: MATERIAL SUEMITTED: RIGHT (MOD) RADICAL MASTECTOMY, PROCUREMENT BY SURGICAL PROCEDURE INTRAOPERATIVE CONSULTATION: COnsulr: Left breast tissue: Breast tissue with nipple/areola complex: Multilobed, diffuse breast mass with. multifocal,  Individual firm secondary masses, malignant. Total dimension to be determined with gross. ADDENDA: Addendum FINAL DIAGNOSIS: ER/PR IMMUNOPEROXIDASE IDENTIFICATION OF KSTROCEN AND PROGESTERONE RECEPTORS IS CARRIED CUT ON SLIDE "A2". DISTINCT INTRANUCLEAR STAINING IS IDENTIFIED FOR ESTROCN RECEPTOR (9Ot) AND PROGESTERONE RECEPTOR (40t) . THEREFORE, BOTH ARE INTERDRETED AS POSITIVE. HER-2/NEU C-OrbB2 (HER-2/NEU) DMOSUNOSTAINING IS CARRIED OUT ON SURGICAL S BLOCK "A2" (BREAST CANCER) USING A 1:30O DILUTION OF DARO'S POLYCLONAL ANTIBODY A48S (DIRECTED AGAINST THE INTRACELLULAR DOKAIN OF c-OrbB2) WITHOUT ANTIGEN RETRIEVAL. DISTINCT COKPLETE MDQRANE STAININC IS IDENTIFIED IN 3O% Or TUMOR CELLS. THEREFORE, c-erbB2 (HER-2/NEU) IS INTERPRETED AS POSITIVE (SCORE 2+). My signature is attestation that I have personalry!. diagnosis roflects that evaluation. (LEFT BREAST,. MODIFIED RADICAL MASTECTCMY: INFILTRATING AND INTRADUCTAL CARCINOMA OE THE BREAST, POOR NUCLEAR GRADE INTRADUCTAL CARCINOMA IS COMEDO-TYPE AND COMPRISES APPROXIMATELY 35: OF TUMOR VOLUME 9CM IN-SITU COMPONENT EXTENDS TO INVOLVE LARGE NIPPLE DUCTSS NIPPL. SHOWING PAGET'S DISEASE TUMOR VASCULAR SPACE INVOLVING IS NOT PROMINENT  SURGICAL MARGINS FREE OF TUMOR IN PLANES OF SECTIONS TUSOR INVOLVES ALL FOUR QUADRANTS, HOWEVER, RANDOM SECTIONS OF QUADRANTS ARE NEGATIVE FOR TUMON